Cambria Gold Mines FY26 Q2 net loss narrows to CAD 2.96 million
Reuters2026/08/29 04:28Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
- Cambria posted a net loss of CAD 78.33 million for the six months ended June 30, 2026; loss per share narrowed to CAD 0.23.
- Second-quarter net loss narrowed to CAD 2.96 million; per-share loss tightened to CAD 0.01.
- Cash and cash equivalents climbed 83.18% to CAD 142.77 million; working capital totaled CAD 98.82 million.
- Financing cash inflows rose to CAD 112.26 million, driven by CAD 131.85 million of share issuance proceeds during the half-year.
- Management expects available funds to cover development at Premier and Red Mountain, mine-site activities, and corporate needs for 12 months.
Disclaimer:
This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cambria Gold Mines Inc. published the original content used to generate this news brief on August 29, 2026, and is solely responsible for the information contained therein.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!
You may also like
TRUMP rises nearly 8% in 24 hours, market capitalization reaches $2.037 billions
BlockBeats•2026/08/29 04:20
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.
Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.
智通财经•2026/08/29 03:22

Crypto prices
MoreBitcoin
BTC
$77,658.06
-2.43%
Ethereum
ETH
$2,440.06
-1.76%
Tether USDt
USDT
$0.9999
-0.01%
BNB
BNB
$690.76
-2.56%
XRP
XRP
$1.39
-2.36%
USDC
USDC
$0.9999
+0.01%
Solana
SOL
$104.12
-2.60%
TRON
TRX
$0.3403
+0.41%
Hyperliquid
HYPE
$81.91
-1.26%
Zcash
ZEC
$798.5
+1.63%
How to buy BTC
Bitget lists BTC – Buy or sell BTC quickly on Bitget!
Trade now
Become a trader now?A welcome pack worth 6200 USDT for new users!
Sign up now